News

New data show clinical safety and early efficacy of SANA, a first-in-class compound that targets creatine-dependent thermogenesis MONTEVIDEO, Uruguay, June 16, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma, a ...
Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...
Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, ...
DelveInsight’s, “Nonalcoholic Steatohepatitis Pipeline Insight, 2025” report provides comprehensive insights about 80+ ...
Learn the 3 critical warning signs that your body is developing diabetes before it's too late. Early detection can prevent ...
Cinnamon may boost metabolism, reduce inflammation, and support heart health. Learn why this is a must-have spice here.
The drug, Mazdutide, is the world's first and currently only GCG/GLP-1 dual receptor agonist targeting both weight loss and ...
Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
A compound derived from traditional Chinese medicine could open new avenues in the fight against obesity. Halofuginone, known ...
Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...